Skip to main content
. Author manuscript; available in PMC: 2013 Feb 7.
Published in final edited form as: Vaccine. 2009 Aug 15;27(44):6239–6246. doi: 10.1016/j.vaccine.2009.07.108

Figure 1. Western blot analysis of serum samples from the day before i.n. challenge.

Figure 1

C. trachomatis MoPn EB were used as the antigen. Lane 1, molecular weight standards. Lane 2, control mAb MoPn-40. Lanes 3 to 7, sera from mice immunized with MOMP and CTB-CpG-1826 (lane 3); with MOMP and CT + CpG-1826 (lane 4); with ovalbumin and CTB-CpG-1826 (lane 5); with ovalbumin and CT + CpG-1826 (lane 6); with C. trachomatis MoPn EB (lane 7). Lane 8, serum from d0.